DE60123934D1 - Das parkin-protein als ubiquitinligase - Google Patents

Das parkin-protein als ubiquitinligase

Info

Publication number
DE60123934D1
DE60123934D1 DE60123934T DE60123934T DE60123934D1 DE 60123934 D1 DE60123934 D1 DE 60123934D1 DE 60123934 T DE60123934 T DE 60123934T DE 60123934 T DE60123934 T DE 60123934T DE 60123934 D1 DE60123934 D1 DE 60123934D1
Authority
DE
Germany
Prior art keywords
ubiquitinligase
parkin protein
parkin
protein
image
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60123934T
Other languages
English (en)
Other versions
DE60123934T2 (de
Inventor
Yoshikuni Mizuno
Nobuyoshi Shimizu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim International GmbH
Original Assignee
Boehringer Ingelheim International GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim International GmbH filed Critical Boehringer Ingelheim International GmbH
Application granted granted Critical
Publication of DE60123934D1 publication Critical patent/DE60123934D1/de
Publication of DE60123934T2 publication Critical patent/DE60123934T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/93Ligases (6)
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896Neurological disorders, e.g. Alzheimer's disease
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00Screening for compounds of potential therapeutic value
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00Screening for compounds of potential therapeutic value
    • G01N2500/10Screening for compounds of potential therapeutic value involving cells
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/28Neurological disorders
    • G01N2800/2835Movement disorders, e.g. Parkinson, Huntington, Tourette

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Neurology (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Noodles (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Image Processing (AREA)
DE60123934T 2000-02-24 2001-02-26 Das parkin-protein als ubiquitinligase Expired - Fee Related DE60123934T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000047801 2000-02-24
JP2000047801 2000-02-24
PCT/JP2001/001399 WO2001062957A1 (fr) 2000-02-24 2001-02-26 Proteine parkine utilisee comme ubiquitine ligase

Publications (2)

Publication Number Publication Date
DE60123934D1 true DE60123934D1 (de) 2006-11-30
DE60123934T2 DE60123934T2 (de) 2007-10-18

Family

ID=18569991

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60123934T Expired - Fee Related DE60123934T2 (de) 2000-02-24 2001-02-26 Das parkin-protein als ubiquitinligase

Country Status (10)

Country Link
US (1) US20050042607A1 (de)
EP (1) EP1262557B1 (de)
AT (1) ATE343001T1 (de)
AU (1) AU2001234171A1 (de)
CA (1) CA2398703A1 (de)
DE (1) DE60123934T2 (de)
DK (1) DK1262557T3 (de)
ES (1) ES2272444T3 (de)
MX (1) MXPA02008256A (de)
WO (1) WO2001062957A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE520025T1 (de) * 2005-12-12 2011-08-15 Elan Pharm Inc Test für morbus-parkinson-therapeutika
US8017348B1 (en) * 2005-12-12 2011-09-13 Elan Pharma International Limited Assay for Parkinson's Disease therapeutics

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999040191A1 (fr) * 1998-02-09 1999-08-12 Boehringer Ingelheim International Gmbh Adn ou genes contribuant au developpement de la maladie de parkinson
GB9826276D0 (en) * 1998-12-01 1999-01-20 Univ Leeds Therapeutic agents for use in degenerative disorders
US7070940B2 (en) * 2002-07-18 2006-07-04 Aventis Pharma S.A. Method for determining the ability of a compound to modify the interaction between parkin and the p38 protein

Also Published As

Publication number Publication date
DE60123934T2 (de) 2007-10-18
EP1262557A1 (de) 2002-12-04
AU2001234171A1 (en) 2001-09-03
MXPA02008256A (es) 2003-01-28
ES2272444T3 (es) 2007-05-01
US20050042607A1 (en) 2005-02-24
ATE343001T1 (de) 2006-11-15
CA2398703A1 (en) 2001-08-30
WO2001062957A1 (fr) 2001-08-30
EP1262557B1 (de) 2006-10-18
DK1262557T3 (da) 2006-11-13
EP1262557A4 (de) 2003-05-02

Similar Documents

Publication Publication Date Title
ITPD990279A0 (it) Treppiede perfezionato, in particolare per impieghi ottici e fotografi ci.
DE60238493D1 (de) Is von seltenen zellen verwendete markierte zellen
DE60226028D1 (de) Projektionssystem mit geringem astigmatismus
BR0115124B1 (pt) dispositivo para fundir uma amostra hiperpolarizada sàlida, mÉtodo para produzir uma amostra hiperpolarizada fundida, e, uso de um dispositivo ou mÉtodo.
DE60207160D1 (de) Entwickungseinheit, Prozesskartusche und Bildaufzeichungsmethode
NL1022018A1 (nl) Belichtingswerkwijze.
DE60216538D1 (de) Toner, Entwickler und Bildaufzeichnungsverfahren
DE69931201D1 (de) Photoresist copolymer.
DE60113921D1 (de) Tragbares Kraftwerkzeug
DK1214088T3 (da) Proteiner udtrykt af Mycobacterium tuberculosis og ikke af BCG og anvendelse heraf som diagnostiske reagenser og vacciner
ATE343001T1 (de) Das parkin-protein als ubiquitinligase
DE60208598D1 (de) Toner, Bildherstellungsverfahren und Prozesskassette
DE60208753D1 (de) Infrarotempfindliche photoempfindliche Zusammensetzung
BR0106896B1 (pt) aparelho de projeção centrìfuga.
DE60213084D1 (de) 3,7-DIAZABICYCLOc3.3.1Ü-FORMULIERUNGEN ALS ANTIARRHYTHMIKA
WO2003025134A3 (en) mcFP ENCODING NUCLEIC ACIDS, POLYPEPTIDES, ANTIBODIES AND METHODS OF USE THEREOF
AU2001242507A1 (en) Method, diagnostic kit and microarray for determining the rhesus factor
ATE387455T1 (de) C6- und c9-substituierte chromeno(4,3- c)isoxazoline und ihre verwendung als anti- depressiva
ES1036257Y (es) Foco perfeccionado.
DE69930370D1 (de) Testisspezifische, menschliche proteinase, svph1-8
藤原義弘 Influence of bacterial endosymbionts on host distributions in deep-sea chemosynthetic ecosystems
Sakamoto Toward an Accessible City for Every Person (Part 2)—The Pedestrian Bridges and the Parks—
ES1046749Y (es) Foco empotrable perfeccionado.
ES1046632Y (es) Foco perfeccionado.
IT1320969B1 (it) Gruppo rilevatore di fattori contaminanti, in particolare per studidentistici, e riunito dentale provvisto di detto gruppo rilevatore.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee